Holen Sie sich die Stockscreener-App
62.02
0.30%
0.18
Schlusskurs vom Vortag:
$61.84
Offen:
$61.71
24-Stunden-Volumen:
236.20K
Relative Volume:
0.45
Marktkapitalisierung:
$3.05B
Einnahmen:
$1.12B
Nettoeinkommen (Verlust:
$213.00M
KGV:
14.55
EPS:
4.2622
Netto-Cashflow:
$267.84M
1W Leistung:
-1.34%
1M Leistung:
-1.94%
6M Leistung:
-24.47%
1J Leistung:
-11.49%
1-Tages-Spanne:
$61.12
$62.12
1-Wochen-Bereich:
$60.15
$63.56
52-Wochen-Spanne:
$60.15
$90.04
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
Firmenname
Prestige Consumer Healthcare Inc
Sektor
Telefon
(914) 524-6800
Adresse
660 WHITE PLAINS RD., TARRYTOWN, NY
Vergleichen Sie PBH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PBH
Prestige Consumer Healthcare Inc
|
62.05 | 3.00B | 1.12B | 213.00M | 267.84M | 4.2622 |
|
ZTS
Zoetis Inc
|
143.29 | 63.05B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.79 | 43.33B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.17 | 40.43B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.12 | 22.97B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
433.51 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-24 | Hochstufung | Sidoti | Neutral → Buy |
| 2024-12-09 | Herabstufung | Sidoti | Buy → Neutral |
| 2024-06-21 | Hochstufung | DA Davidson | Neutral → Buy |
| 2022-11-17 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-05-10 | Hochstufung | Jefferies | Hold → Buy |
| 2022-05-09 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-08-07 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-06-29 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-04-14 | Herabstufung | Jefferies | Buy → Hold |
| 2020-04-07 | Fortgesetzt | Sidoti | Neutral |
| 2020-03-26 | Hochstufung | Jefferies | Hold → Buy |
| 2020-03-24 | Eingeleitet | Oppenheimer | Perform |
| 2020-03-19 | Hochstufung | DA Davidson | Neutral → Buy |
| 2019-01-15 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2017-12-04 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-06-02 | Hochstufung | Jefferies | Underperform → Hold |
| 2017-05-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-12-27 | Bestätigt | B. Riley & Co. | Buy |
| 2016-11-17 | Eingeleitet | Gabelli & Co | Buy |
| 2016-08-12 | Hochstufung | Sidoti | Neutral → Buy |
| 2016-03-08 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2016-02-05 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-11-30 | Herabstufung | Jefferies | Hold → Underperform |
| 2014-04-28 | Bestätigt | B. Riley & Co. | Buy |
| 2014-04-28 | Bestätigt | Oppenheimer | Outperform |
| 2013-07-09 | Eingeleitet | B. Riley & Co. | Buy |
Alle ansehen
Prestige Consumer Healthcare Inc Aktie (PBH) Neueste Nachrichten
Statistical indicators supporting Prestige Consumer Healthcare Inc.’s strengthJuly 2025 Sector Moves & Daily Entry Point Trade Alerts - newser.com
Backtesting results for Prestige Consumer Healthcare Inc. trading strategiesMarket Trend Report & Real-Time Price Movement Reports - newser.com
Building trade automation scripts for Prestige Consumer Healthcare Inc.Quarterly Growth Report & Fast Entry Momentum Trade Alerts - newser.com
What to expect from Prestige Consumer Healthcare Inc. in the next 30 daysFed Meeting & Growth Focused Stock Pick Reports - newser.com
Automated trading signals detected on Prestige Consumer Healthcare Inc. - newser.com
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - simplywall.st
How Prestige Consumer Healthcare Inc. stock trades under stagflation2025 Fundamental Recap & Reliable Price Breakout Alerts - newser.com
Will Prestige Consumer Healthcare Inc. stock maintain momentum in 2025Portfolio Risk Summary & Safe Entry Trade Signal Reports - newser.com
Does Prestige Consumer Healthcare Inc. stock trade at a discount to peersEarnings Performance Report & Risk Controlled Stock Pick Alerts - newser.com
Here’s Heartland Value Plus Fund’s Views on Prestige Consumer Healthcare (PBH) - Yahoo
Is this a good reentry point in Prestige Consumer Healthcare Inc.July 2025 Analyst Calls & High Accuracy Swing Entry Alerts - newser.com
Prestige Consumer Healthcare (PBH) Stock Analysis: Unveiling a Potential 35% Upside for Investors - DirectorsTalk Interviews
Can a trend reversal in Prestige Consumer Healthcare Inc. lead to recoveryPortfolio Return Summary & Capital Protection Trade Alerts - newser.com
Will Prestige Consumer Healthcare Inc. stock benefit from automationWeekly Gains Report & Verified Momentum Stock Alerts - newser.com
Why Prestige Consumer Healthcare Inc. stock is popular among millennialsWeekly Gains Report & Free Daily Entry Point Trade Alerts - newser.com
Blair William & Co. IL Buys 7,827 Shares of Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Prestige Consumer Healthcare Inc PBV Stock Analysis and ForecastFinancial Sector Performance & Fast Growing Capital Growth - earlytimes.in
Prestige Consumer Healthcare (NYSE:PBH) Hits New 12-Month LowShould You Sell? - MarketBeat
Prestige Consumer Healthcare stock hits 52-week low at 61.27 USD - Investing.com
Pattern recognition hints at Prestige Consumer Healthcare Inc. upsideWeekly Stock Report & Fast Moving Stock Watchlists - newser.com
Prestige Consumer Healthcare Inc. stock outlook for YEARQuarterly Growth Report & Capital Efficient Trading Techniques - newser.com
Prestige Consumer Healthcare (NYSE:PBH) Receives Hold (C) Rating from Weiss Ratings - MarketBeat
DAVENPORT & Co LLC Purchases 5,264 Shares of Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Will Prestige Consumer Healthcare Inc. (PBV) stock extend growth storyMarket Movers & Fast Entry High Yield Tips - newser.com
Volatility clustering patterns for Prestige Consumer Healthcare Inc.2025 Major Catalysts & Daily Stock Trend Reports - newser.com
Sentiment analysis tools applied to Prestige Consumer Healthcare Inc.Recession Risk & Technical Pattern Recognition Alerts - newser.com
How Prestige Consumer Healthcare Inc. (PBV) stock performs during market turbulence2025 Market WrapUp & Stepwise Trade Signal Guides - newser.com
Why analysts raise outlook for Prestige Consumer Healthcare Inc. stockDip Buying & Long-Term Safe Investment Ideas - newser.com
Prestige Consumer Healthcare Inc. (NYSE:PBH) Receives $94.80 Consensus Target Price from Analysts - Defense World
Prestige Consumer Healthcare Inc. to Release Fiscal 2026 Second Quarter Earnings on November 6, 2025 - Quiver Quantitative
Prestige Consumer Healthcare to Release Fiscal 2026 Second Quarter Earnings Results - The Manila Times
Q2 Results Nov 6: Prestige Consumer Healthcare to Host Webcast and Conference Call - Stock Titan
Real time social sentiment graph for Prestige Consumer Healthcare Inc.Weekly Trade Recap & Fast Entry High Yield Tips - newser.com
Chart based exit strategy for Prestige Consumer Healthcare Inc.Trade Entry Summary & Safe Investment Capital Preservation Plans - newser.com
Is Prestige Consumer Healthcare Inc. stock resilient in recession scenariosJuly 2025 Rallies & AI Powered Buy and Sell Recommendations - newser.com
Full technical analysis of Prestige Consumer Healthcare Inc. stock2025 Valuation Update & Community Supported Trade Ideas - newser.com
Will Prestige Consumer Healthcare Inc. stock maintain strong growthQuarterly Investment Review & Real-Time Buy Zone Alerts - newser.com
Prestige Consumer Healthcare Inc. (NYSE:PBH) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Prestige Consumer Healthcare Stock Hits New 52-Week Low at $61.29 - Markets Mojo
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 100% Above Its Share Price - Yahoo Finance
Finanzdaten der Prestige Consumer Healthcare Inc-Aktie (PBH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.95%
2.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):